Trials / Conditions / FGFR3 Gene Amplification
FGFR3 Gene Amplification
3 registered clinical trials studyying FGFR3 Gene Amplification.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors NCT06777316 | Cogent Biosciences, Inc. | Phase 1 / Phase 2 |
| Unknown | Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations NCT04096417 | Academic and Community Cancer Research United | Phase 2 |
| Completed | Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous C NCT02965378 | SWOG Cancer Research Network | Phase 2 / Phase 3 |